Company overview
Genomenon provides genomic intelligence platforms like Mastermind and Cancer Knowledgebase (CKB) that curate evidence from millions of full-text articles to accelerate variant interpretation for clinical diagnosis and precision medicine. These tools connect genes, variants, diseases, therapies, and clinical trials using AI and expert curation, supporting pharma R&D in identifying biomarkers and genetic drivers. They integrate with analysis software to deliver actionable insights for rare diseases, oncology, and therapeutic development.
Genomenon is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include genomic intelligence, variant interpretation, precision medicine, cancer knowledgebase, mastermind platform.
Structured facts
- Website
- https://www.genomenon.com
- Markets served
- United States & Americas
- Keywords
- genomic intelligence, variant interpretation, precision medicine, cancer knowledgebase, mastermind platform
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What are Genomenon's key platforms and capabilities?
- Mastermind offers gene- and variant-level insights from over 11M full-text articles and 3.7M supplemental texts, using AI and expert curation for variant interpretation. Cancer Knowledgebase (CKB) interprets cancer genomic profiles with protein impact, therapies, and trials. Both support clinical decisions in rare diseases and oncology.
- How does Genomenon ensure data accuracy and currency?
- Genomenon employs genomics-focused AI to index the human genome and expert genetic scientists to curate evidence per clinical guidelines like ACMG. Content updates weekly with new peer-reviewed publications, clinical trials, and supplemental data for comprehensive, evidence-based genomic datasets.
- What integrations and geographies does Genomenon support?
- Platforms integrate with tools like Golden Helix VarSeq for unified workflows. Genomenon serves global clinicians, researchers, and pharma developers by indexing worldwide literature, with no geographic restrictions specified.
Related editorial coverage
- Bio-IT World Conference: Oncology Highlights - Day 1
- BioMed Israel 2024: Key Innovations and US Partnerships
- US-Japan Healthcare Conf: Key Takeaways for 2026
- Oncology Data Landscape 2026: Key Trends & Upcoming Readouts
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- Brazilian Oncology Market: Growth of Precision Medicine & Biomarker Testing
Explore lab tools and QA/QC resources for R&D teams.
